We evaluated the vaccine-induced immune responses and anti-cancer efficacy in inbred mice, and we found that the HERV-W vaccine elicited both T-cell responses to different domains of the Env protein and the antibody recognition of the native form of Syncytin-1, which was expressed on the surfaces of the mouse cancer cells [18]. This evidence concerns the gene ERVW-1 and cancer.